Suppr超能文献

普通人群中脂肪肝的发病率及自然病程:狄俄尼索斯研究

Incidence and natural course of fatty liver in the general population: the Dionysos study.

作者信息

Bedogni Giorgio, Miglioli Lucia, Masutti Flora, Castiglione Anna, Crocè Lory Saveria, Tiribelli Claudio, Bellentani Stefano

机构信息

Liver Research Center, AREA Science Park, Basovizza, Trieste, Italy.

出版信息

Hepatology. 2007 Nov;46(5):1387-91. doi: 10.1002/hep.21827.

Abstract

UNLABELLED

Using the general population of the Dionysos Study, we followed up 144 subjects without fatty liver (FL(-)) and 336 with fatty liver (FL(+)) for a median time of 8.5 years. All subjects had suspected liver disease (SLD) defined as altered liver enzymes, high mean corpuscular volume, or low platelet count in the absence of HBV and HCV infection. Ethanol intake was assessed using a food frequency questionnaire, and FL was diagnosed using ultrasonography. The incidence and remission rates of FL were 18.5 and 55.0 per 1,000 person-years. Progression to cirrhosis or HCC was rare in both cohorts (incidence rate: 1.7 versus 1.1 and 0.8 versus 0.4 per 1,000 person-years for FL(-) versus FL(+)). Multivariable Poisson regression was performed to identify predictors of FL incidence and remission among sex, age, body mass index, ethanol, and liver enzymes. Every increase of 20 g/day of ethanol intake at baseline was associated with a 17% increase in the rate of incident FL (P = 0.019), a 10% decrease in the rate of remitting FL and SLD (P = 0.043), a 19% decrease in the rate of remitting FL with persistent SLD (P = 0.002), and a 10% increase in mortality rate (P = 0.005) in the FL(+) cohort.

CONCLUSION

In the general population of the Dionysos Study, FL regressed in nearly 1 of every 2 cases and had a substantially benign course. Ethanol intake was the most important risk factor for FL remission and incidence and a predictor of mortality in subjects with FL.

摘要

未标注

在狄俄尼索斯研究的普通人群中,我们对144名无脂肪肝(FL(-))和336名有脂肪肝(FL(+))的受试者进行了随访,中位随访时间为8.5年。所有受试者均有疑似肝病(SLD),定义为在无HBV和HCV感染的情况下肝酶改变、平均红细胞体积升高或血小板计数降低。使用食物频率问卷评估乙醇摄入量,通过超声检查诊断脂肪肝。脂肪肝的发病率和缓解率分别为每1000人年18.5例和55.0例。两个队列中进展为肝硬化或肝癌的情况均很少见(发病率:FL(-)队列与FL(+)队列分别为每1000人年1.7例对1.1例以及0.8例对0.4例)。进行多变量泊松回归以确定性别、年龄、体重指数、乙醇和肝酶中脂肪肝发病率和缓解的预测因素。基线时乙醇摄入量每增加20克/天,FL(+)队列中脂肪肝发病率增加17%(P = 0.019),脂肪肝和SLD缓解率降低10%(P = 0.043),持续性SLD患者的脂肪肝缓解率降低19%(P = 0.002),死亡率增加10%(P = 0.005)。

结论

在狄俄尼索斯研究的普通人群中,近二分之一的脂肪肝病例病情出现逆转,且病程基本呈良性。乙醇摄入量是脂肪肝缓解、发病的最重要风险因素,也是脂肪肝患者死亡率的预测因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验